Clinical Trial Update: Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy of ciclesonide compared with the fixed-dose combination of fluticasone propionate/salmeterol and placebo in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate/salmeterol (fluticasone propionate/salmeterol)
• ciclesonide (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED